Preventing Recurrent Preeclampsia by Tailored Treatment of Nonphysiologic Hemodynamic Adjustments to Pregnancy

Hypertension. 2021 Jun;77(6):2045-2053. doi: 10.1161/HYPERTENSIONAHA.120.16502. Epub 2021 Apr 5.

Abstract

[Figure: see text].

Trial registration: ClinicalTrials.gov NCT04216706.

Keywords: hemodynamics; hypertension; physiology; preeclampsia; pregnancy.

MeSH terms

  • Adult
  • Antihypertensive Agents / administration & dosage
  • Antihypertensive Agents / therapeutic use
  • Blood Pressure / drug effects
  • Blood Pressure / physiology*
  • Female
  • Hemodynamics / drug effects
  • Hemodynamics / physiology*
  • Humans
  • Labetalol / administration & dosage
  • Labetalol / therapeutic use
  • Methyldopa / administration & dosage
  • Methyldopa / therapeutic use
  • Nifedipine / administration & dosage
  • Nifedipine / therapeutic use
  • Pre-Eclampsia / physiopathology
  • Pre-Eclampsia / prevention & control*
  • Pregnancy
  • Secondary Prevention

Substances

  • Antihypertensive Agents
  • Methyldopa
  • Nifedipine
  • Labetalol

Associated data

  • ClinicalTrials.gov/NCT04216706